INH AIRFLOW 250
Salmeterol (50mg), Fluticasone (250mg)
INH AIRFLOW 250 combination of Salmeterol (50mcg) and Fluticasone (250mcg) are combined inhaled medications used to treat asthma and chronic obstructive pulmonary disease (COPD). This combination helps in managing airway inflammation and improving respiratory symptoms.
How Salmeterol (50mcg), Fluticasone (250mcg) Works :
- Salmeterol is a long-acting beta agonist (LABA) that relaxes the muscles around the airways, making breathing easier.
- Fluticasone is a corticosteroid that reduces inflammation in the airways, alleviating symptoms like wheezing and shortness of breath.
Indications for Salmeterol (50mcg), Fluticasone (250mcg) :
- Asthma Management: This combination is prescribed for long-term asthma management to prevent asthma attacks and improve lung function.
- COPD Treatment: It is also used to manage COPD symptoms and reduce exacerbations.
Dosage and Administration :
- The typical dosage of Salmeterol (50mcg), Fluticasone (250mcg) is usually two puffs twice daily, administered through a metered-dose inhaler (MDI) or dry powder inhaler (DPI).
- Patients should rinse their mouth after inhalation to prevent oral thrush.
- Adherence to the prescribed dosage and administration instructions is crucial for optimal therapeutic outcomes.
Safety and Side Effects :
- Common side effects may include throat irritation, hoarseness, cough, and headache.
- Severe adverse effects such as paradoxical bronchospasm or allergic reactions are rare but require immediate medical attention.
Precautions and Contraindications :
- Patients with known hypersensitivity to Salmeterol, Fluticasone, or any components of the medication should avoid its use.
- Salmeterol should not be used as a rescue inhaler during acute asthma attacks; patients should have a separate short-acting bronchodilator for such situations.
Conclusion :
Salmeterol (50mcg) and Fluticasone (250mcg) combination therapy is an effective option for managing asthma and COPD, providing symptom control and improving lung function. Patients should follow their healthcare provider's instructions for proper usage and consult them for any concerns or adverse reactions.Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.
For further information :
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 7877551268, 7849827488